Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Hepatology Année : 2018

Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial

(1) , (2) , (1) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12, 10) , (13, 14) , (15, 16) , (17, 18) , (19) , (20) , (21, 22) , (23, 24) , (25) , (26) , (27) , (1) , (2) , (2) , (1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Fichier non déposé

Dates et versions

hal-03590865 , version 1 (28-02-2022)

Identifiants

Citer

C. Corpechot, A. Rousseau, O. Chazouilleres, L. G. Antonia, F. Habersetzer, et al.. Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial. Journal of Hepatology, 2018, 68 (1), pp.S4-S5. ⟨10.1016/S0168-8278(18)30226-5⟩. ⟨hal-03590865⟩
23 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More